Holen Sie sich die Stockscreener-App
9.49
12.13%
-1.31
Handel nachbörslich:
9.33
-0.16
-1.69%
Schlusskurs vom Vortag:
$10.80
Offen:
$11.11
24-Stunden-Volumen:
334.18K
Relative Volume:
8.66
Marktkapitalisierung:
$253.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-13.10%
1M Leistung:
-37.75%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.25
$11.51
1-Wochen-Bereich:
$9.25
$11.51
52-Wochen-Spanne:
$9.25
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
Firmenname
Conexeu Sciences Inc
Sektor
Branche
Telefon
604-315-4722
Adresse
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
9.49 | 288.99M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Conexeu Sciences Inc Aktie (CNXU) Neueste Nachrichten
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It - PR Newswire
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Enterprise value to EBITDA forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Conexeu Sciences (CNXU) Earnings Date and Reports 2026 - MarketBeat
Conexeu Sciences Inc. Common Stock (NASDAQ: CNXU) Stock Price, News & Analysis - Kalkine
Price to book forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Enterprise value to revenue forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Price to sales forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity - Investing News Network
CNXU News Today | Why did Conexeu Sciences stock go up today? - MarketBeat
Conexeu Sciences (CNXU) Stock Forecast and Price Target 2026 - MarketBeat
Conexeu Sciences : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
50,000 options reported by Conexeu Sciences (CNXU) director - Stock Titan
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CNXU Forecast — Price Target — Prediction for 2027 - TradingView
Conexeu Sciences, Inc. Actuals & Estimates (NASDAQ:CNXU) - TradingView
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat
Conexeu Sciences opens R&D facility in Vancouver - Investing.com
The Aesthetics Giants Just Confirmed "Ozempic Face" Is Realand a Newly Public Regenerative Player Wants to Compete for It - Investing News Network
Conexeu Sciences opens R&D facility in Vancouver By Investing.com - Investing.com Australia
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform - The Manila Times
Conexeu Launches R&D Facility at M4 to Innovate Wound Healing Tech - techcouver.com
Conexeu Sciences Inc.: Target Price Consensus and Analysts Recommendations | CNXU | US20715F1003 - marketscreener.com
Conexeu Sciences (CNXU) director holds 50K options at $2.30, 2031 expiry - Stock Titan
Conexeu Sciences aims for FDA clearance by 2027 with a promising regenerative medicine product. - Pluang
Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission - Seeking Alpha
Insider Stock Purchases: June 24, 2026 - Moomoo
TradingKey - TradingKey
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conexeu Sciences Ord Shs (CNXU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conexeu Sciences Ord Shs (CNXU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Conexeu Sciences Ord Shs (CNXU) Valuation: PE, PB & Fair Value Analysis - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.860|Chg%:0.60 - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.360|Chg%:-0.33 - TradingKey
Conexeu Sciences Ord Shs (CNXU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conexeu Sciences Ord Shs (CNXU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Conexeu Sciences Ord Shs (CNXU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.820|Chg%:0.27 - TradingKey
[Form 3] Conexeu Sciences Inc. Initial Statement of Beneficial Ownership - Stock Titan
Insider at Conexeu Sciences (CNXU) adds common stock and warrants - Stock Titan
Homegrown biotech firm launches new R&D lab space in Vancouver - Business in Vancouver
This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
H.C. Wainwright Initiates Conexeu Sciences(CNXU.US) With Buy Rating, Announces Target Price $20 - Moomoo
Conexeu Sciences (CNXU) 10% owner exercises 250K warrants via N3GU - Stock Titan
Conexeu Sciences initiated with a Buy at H.C. Wainwright - TipRanks
CNXU Initiates Coverage by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Conexeu Sciences stock initiated at buy by H.C. Wainwright, $20 target - Investing.com South Africa
HC Wainwright Initiates Conexeu Sciences at Buy With $20 Price Target - Moomoo
Finanzdaten der Conexeu Sciences Inc-Aktie (CNXU)
Es liegen keine Finanzdaten für Conexeu Sciences Inc (CNXU) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Conexeu Sciences Inc-Aktie (CNXU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wright Michael G. | 10% Owner |
Jun 18 '26 |
Option Exercise |
0.00 |
250,000 |
250 |
2,148,048 |
| Wright Michael G. | 10% Owner |
May 26 '26 |
Option Exercise |
0.00 |
400,000 |
400 |
1,898,048 |
| Sharpe Jeffrey Nathan | Director |
May 22 '26 |
Option Exercise |
0.00 |
500,000 |
500 |
1,000,000 |
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):